The German life-science and chemicals company attributed earnings growth to a recovery of its life-science segment, cost discipline and lower spending on research and development following the ...

Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...

The company's adjusted earnings per share stood at 2.30 euros compared with 2.07 euros in the prior-year period. Merck made an after-tax profit of 812 million euros compared with 740 million in the ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...

Collaborations: Mersana continues to advance its Johnson & Johnson and Merck KGaA ... in the same location following the ...

2024 Merck , known as MSD outside of the United States and Canada, today announced that new clinical and real-world data for ...

The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to IO102-IO103. IO Biotech is ...

In the heart of Southwestern Kenya lies Lambwe Valley, where the Ruma National Park is also located. Here, wild animals such ...

Pet store Pet Evolution and wellness company Saint have signed 10-year leases for a total of 3,100 square feet at MAG ...